Aqua Bio Technology ASA (OSTO:ABTO) Research & Development: kr0.00 Mil (TTM As of Dec. 2025)


OSTO:ABTO Aqua Bio Technology ASA OSTO:ABTO
29 GF Score
Price kr6.82
GF Value kr3.37
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Aqua Bio Technology ASA Research & Development?

Aqua Bio Technology ASA OSTO:ABTO 29 Research & Development is kr0.00 Mil as of Dec. 2025. GuruFocus rates OSTO:ABTO with a GF Score™ of 29/100 and a GF Value™ of kr3.37 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Aqua Bio Technology ASA's Research & Development for the three months ended in Dec. 2025 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was kr0.00 Mil.

Aqua Bio Technology ASA  (OSTO:ABTO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aqua Bio Technology ASA Research & Development Related Terms

Aqua Bio Technology ASA Research & Development Historical Data

* Premium members only.

The historical data trend for Aqua Bio Technology ASA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aqua Bio Technology ASA Research & Development Chart

Aqua Bio Technology ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aqua Bio Technology ASA Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:ABTO
29GF Score
Aqua Bio Technology ASA OSTO:ABTO
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aqua Bio Technology ASA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0.00 Mil mean?
Aqua Bio Technology ASA (OSTO:ABTO) has a Research & Development of kr0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Aqua Bio Technology ASA and its competitors.
Is Aqua Bio Technology ASA's Research & Development too high?
Aqua Bio Technology ASA's current Research & Development is kr0.00 Mil. Overall, Aqua Bio Technology ASA has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aqua Bio Technology ASA's Research & Development compare to VRTX and REGN?
Aqua Bio Technology ASA's Research & Development of kr0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aqua Bio Technology ASA and its competitors. Aqua Bio Technology ASA's current Research & Development is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aqua Bio Technology ASA stock overvalued right now?
Based on GuruFocus' analysis, Aqua Bio Technology ASA (OSTO:ABTO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr3.37, compared to a current price of kr6.82 — trading 102.4% above its estimated fair value. The current Research & Development is kr0.00 Mil. Aqua Bio Technology ASA's overall GF Score™ is 29/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aqua Bio Technology ASA (OSTO:ABTO), the current Research & Development is kr0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aqua Bio Technology ASA (OSTO:ABTO) Overvalued in 2026?

Based on GuruFocus' analysis, Aqua Bio Technology ASA stock appears to be overvalued. The current stock price of kr6.82 is trading 102.4% above its estimated GF Value™ of kr3.37. GuruFocus considers Aqua Bio Technology ASA to be Significantly Overvalued.

Key valuation signals for OSTO:ABTO:

  • Research & Development: kr0.00 Mil
  • GF Value™: kr3.37 vs. price of kr6.82 (102.4% above fair value)
  • GF Score™: 29/100 with 5 warning signs

No single metric tells the full story. See the OSTO:ABTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aqua Bio Technology ASA Business Description

Address Bygdoy Alle, Oslo, NOR, 0257
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.
29GF Score

Get the complete analysis for OSTO:ABTO

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr6.82
Price
kr3.37
GF Value